Nanotechnology Now - Press Release: Market Research Forecasts Nanotechnology-Enabled Drug Delivery Market at $136 Billion by 2021

Home > Press > Market Research Forecasts Nanotechnology-Enabled Drug Delivery Market at $136 Billion by 2021

Abstract:
MarketResearch.com has announced the addition of the new report "Nanotechnology for Drug Delivery: Global Market for Nanocarriers" to their collection of Biotechnology market reports. For more information, visit www.marketresearch.com/Cientifica-Ltd-v2574/Nanotechnology-Drug-Delivery-Global-Nanocarriers-6856624/

Market Research Forecasts Nanotechnology-Enabled Drug Delivery Market at $136 Billion by 2021

Rockville, MD | Posted on March 27th, 2012

Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total addressable market. Liposomes will offer the largest addressable market ($15 billion) in 2021 while gold nanocarriers will see the highest compound annual growth rate (CAGR) -- 53.8% -- in the next decade.

Drugs are loaded into nanocarriers (also called nanoshells or nanoparticles, between 1 and 100 nm), then transported through the body to the target site. This kind of targeted drug delivery for the treatment of cancers is one of the most anticipated and discussed benefits of nanotechnology-enabled medicine as it offers a level of accuracy in delivering drugs that far surpasses present methods. Typically over 90% of a drug is wasted in the body, which leads to unwanted side effects. Modern chemotherapy bombards patients with drugs in the hope that tumorous cells will be destroyed. The lack of specificity of current drug delivery techniques mean patients' healthy cells are destroyed indiscriminately along with cancer cells.

Using nanotechnology to combat cancer is not new. Abraxane, the first nanoparticulate drug delivery product for the treatment of breast cancer, launched six years ago. There are now hundreds of new nanotech-based treatments under development, ranging from reformulation of existing drugs to enhance their efficacy to radical new "magic bullet" therapies.

The healthcare market is changing. We are seeing a paradigm shift away from blockbusters and a 'one-size fits all' approach to a more personalized medicine based on an individual's unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become.

For more information, visit www.marketresearch.com/Cientifica-Ltd-v2574/Nanotechnology-Drug-Delivery-Global-Nanocarriers-6856624/

####

About MarketResearch.com
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance.

For more information, please click here

Contacts:
Veronica Franco
MarketResearch.com
240.747.3016

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: